William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 322 shares at $4.70 ($2K) on 2022-07-22, disclosed to the SEC on 2022-07-26.
Open-market sale of $2k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2024-11-22 | $171K | — | Filing → |
| IMVT | SELL | 2024-10-18 | $167K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $189K | — | Filing → |